Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 376 | 413 | 413 | 601 | 3,227 |
| Gross Profit | 376 | 413 | 413 | 601 | 3,227 |
| Operating Expenses | 5,838 | 7,744 | 6,779 | 6,259 | 5,830 |
| Operating Income | -5,462 | -7,331 | -6,366 | -5,658 | -2,603 |
| Other Income | -542 | -383 | 350 | 2,395 | -1,334 |
| Pre-tax Income | -6,004 | -7,714 | -6,016 | -3,263 | -3,937 |
| Net Income Continuous | -6,004 | -7,714 | -6,016 | -3,263 | -3,937 |
| Net Income | $-6,004 | $-7,714 | $-6,016 | $-3,263 | $-3,937 |
| EPS Basic Total Ops | -0.32 | -0.51 | -0.42 | -0.23 | -0.27 |
| EPS Basic Continuous Ops | -0.33 | -0.51 | -0.42 | -0.23 | -0.27 |
| EPS Diluted Total Ops | -0.32 | -0.51 | -0.42 | -0.23 | -0.12 |
| EPS Diluted Continuous Ops | -0.34 | -0.51 | -0.42 | -0.23 | -0.27 |
| EBITDA(a) | $-5,296 | $-7,164 | $-6,117 | $-5,376 | $-2,319 |